BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14742984)

  • 1. Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy. A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy.
    Gonzalez Molina M; Seron D; Garcia del Moral R; Carrera M; Sola E; Jesus Alferez M; Gomez Ullate P; Capdevila L; Gentil MA
    Transplantation; 2004 Jan; 77(2):215-20. PubMed ID: 14742984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
    Sumethkul V; Changsirikulchai S; Lothuvachai T; Chalermsanyakorn P
    Transplant Proc; 2006 Dec; 38(10):3470-2. PubMed ID: 17175307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil-induced reversal of glomerular filtration loss in children with chronic allograft nephropathy.
    Henne T; Latta K; Strehlau J; Pape L; Ehrich JH; Offner G
    Transplantation; 2003 Nov; 76(9):1326-30. PubMed ID: 14627911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
    Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
    Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
    Grebe SO; Mueller TF; Troeltsch M; Ebel H; Lange H
    Transplant Proc; 2004 Dec; 36(10):2974-8. PubMed ID: 15686673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-dose cyclosporine with mycophenolate mofetil and prednisone significantly improves the long-term glomerular filtration rate and graft survival.
    Wang R; Xu Y; Wu J; Wang Y; He Q; Chen J
    Intern Med; 2013; 52(9):947-53. PubMed ID: 23648712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: a retrospective analysis.
    Benz K; Plank C; Griebel M; Montoya C; Dötsch J; Klare B
    Pediatr Transplant; 2006 May; 10(3):331-6. PubMed ID: 16677357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience of mycophenolate mofetil in the treatment of chronic allograft nephropathy in kidney transplantation: three-year follow-up.
    Chu SH; Wu CT; Chou CC; Chen Y; Liu KL; Chiang YJ
    Transplant Proc; 2004 Sep; 36(7):2073-5. PubMed ID: 15518750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.
    Gonwa T; Johnson C; Ahsan N; Alfrey EJ; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Leonhardt M; Fitzsimmons WE
    Transplantation; 2003 Jun; 75(12):2048-53. PubMed ID: 12829910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of pediatric transplant recipients: mycophenolic acid trough levels are not a good indicator for long-term graft function.
    Pape L; Ehrich JH; Offner G
    Clin Transplant; 2004 Oct; 18(5):576-9. PubMed ID: 15344963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
    Zhu B; Liu Z; Wu C; Wang P; Wang X; Xu H
    Transplant Proc; 2008 Sep; 40(7):2258-61. PubMed ID: 18790207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil in pediatric renal transplantation.
    Benfield MR; Symons JM; Bynon S; Eckhoff D; Herrin J; Harmon W; Kohaut E
    Pediatr Transplant; 1999 Feb; 3(1):33-7. PubMed ID: 10359029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of azathioprine to mycophenolate mofetil and chronic graft failure progression.
    Lezaic VD; Marinkovic J; Ristic S; Dokic ZM; Basta Jovanovic G; Radivojevic DM; Blagojevic RN; Djukanovic LD
    Transplant Proc; 2005 Mar; 37(2):734-6. PubMed ID: 15848517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients.
    Hamour IM; Lyster HS; Burke MM; Rose ML; Banner NR
    Transplantation; 2007 Mar; 83(5):570-6. PubMed ID: 17353776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved long-term allograft function in pediatric renal transplantation with mycophenolate mofetil.
    Ferraris JR; Ghezzi LF; Vallejo G; Piantanida JJ; Araujo JL; Sojo ET
    Pediatr Transplant; 2005 Apr; 9(2):178-82. PubMed ID: 15787789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience.
    Dumortier J; Guillaud O; Pittau G; Salandre J; Adham M; Scoazec JY; Boillot O
    Transplant Proc; 2010 Sep; 42(7):2602-6. PubMed ID: 20832553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy.
    Stoves J; Newstead CG; Baczkowski AJ; Owens G; Paraoan M; Hammad AQ
    Nephrol Dial Transplant; 2004 Aug; 19(8):2113-20. PubMed ID: 15161956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.